Abstract:Objective To investigate the differences in intestinal microbiota between patients with liver cirrhosis and those with hepatocellular carcinoma (HCC) complicated by liver cirrhosis,as well as the association between the change in intestinal microbiota and the development of HCC.Methods A total of 35 patients with chronic liver diseases who were hospitalized in Department of Hepatology in Tianjin Third Central Hospital from December 2015 to May 2016 were enrolled,among whom 20 patients had liver cirrhosis (liver cirrhosis group) and 15 had HCC complicated by liver cirrhosis (HCC group).Fecal samples were collected from all patients,total bacterial DNA was extracted,and Roche 454 sequencing was used to determine the sequence of the V3-V6 viable regions of 16S rDNA.A bioinformatics analysis was also performed (species taxonomy,abundance analysis,and diversity analysis).The t-test was used for comparison of continuous data between groups,and the Mann-Whitney U test was used for comparison of categorical data between groups.Results The mean number of operational taxonomic units (OTUs) in the samples from the 20 liver cirrhosis patients was 306.50-± 163.76,and that in the samples from the 15 HCC patients was 357.24 -± 168.85;there were no significant differences in the number of OTUs and alpha diversity between the two groups of patients (both P ＞0.05).The bacteria in fecal samples included Actinobacteria,Bacteroidetes,Firmicutes,and Proteobacteria.Genus-species and composition analyses showed that there was a significant difference in relative abundance of various bacteria in the intestine between the liver cirrhosis group and the HCC group,and compared with the HCC group,the liver cirrhosis group had significant increases in the proportions of Actinobacteria (0.21％ vs 0.06％,U =89.000,P =0.043),Bifidobacterium (0.16％ vs 0.04％,U =90.000,P =0.046),and Clostridium (0.13％ vs 0.08％,U =90.000,P =0.046) and significant reductions in the proportions of Rikenellaceae (0.58％ vs 2.30％,U =82.000,P =0.023) and Christenellaceae (0.01％ vs 0.08％,U =84.500,P =0.028).Conclusion There are significant differences in the composition of intestinal microbiota between patients with liver cirrhosis and those with HCC complicated by liver cirrhosis,while the specific mech anisms of the interaction between the differences and HCC with liver citrhosis remained unclear.

Characteristics of Three Microbial Colonization States in the Duodenum of the Cirrhotic Patients.

Characterization of Fecal Microbial Communities in Patients with Liver Cirrhosis.

Dysbiosis of small intestinal microbiota in liver cirrhosis and its association with etiology

Characterization of the Gastric Mucosal Microbiota in Patients with Liver Cirrhosis and Its Associations with Gastrointestinal Symptoms

Disordered Intestinal Microbial Communities During Clostridioides difficile Colonization and Subsequent Infection of Hepatic Cirrhosis Patients in a Tertiary Care Hospital in China

Intestinal Microbiota Was Assessed in Cirrhotic Patients with Hepatitis B Virus Infection

The causal relationship between gut microbiota and end-stage liver disease: a bidirectional Mendelian randomization analysis

Comparison of the Gut Microbe Profiles and Numbers Between Patients with Liver Cirrhosis and Healthy Individuals

Intestinal Microbiota and Innate Immunity-Related Gene Alteration in Cirrhotic Rats with Liver Transplantation

Disorganized Gut Microbiome Contributed to Liver Cirrhosis Progression: A Meta-Omics-Based Study

Functional gene arrays-based analysis of fecal microbiomes in patients with liver cirrhosis

Characteristics of the Intestinal Bacterial Microbiota Profiles in Bifidobacterium Pseudocatenulatum LI09 Pre-Treated Rats with D-galactosamine-induced Liver Injury

Molecular Ecological Structure of Intestinal Fungal Flora in Patients with Chronic Hepatitis B Infection

Changes of Fecal Bifidobacterium Species in Adult Patients with Hepatitis B Virus-Induced Chronic Liver Disease

A Preliminary Analysis of Composition and Structure of Intestinal Microbiota in Patients with Liver Cirrhosis or Hepatocellular Carcinoma

Characterization of the Circulating Microbiome in Acute-on-chronic Liver Failure Associated with Hepatitis B.

Alterations of the human gut microbiome in liver cirrhosis

Metabolomic analyses of faeces reveals malabsorption in cirrhotic patients.

The signatures and crosstalk of gut microbiome, mycobiome, and metabolites in decompensated cirrhotic patients

IDDF2024-ABS-0186 Analysis of the Correlation Between Gut Microbiota and Disease Severity in Patients with Primary Biliary Cholangitis

The community structure of intestinal bacteria from cirrhosis patients and its influence factors